Mathematical model of HPV provides insight into impacts of risk factors and vaccine.
Kim
Jane J
JJ
Harvard School of Public Health, Boston, Massachusetts, United States of America. jkim@hsph.harvard.edu
D017281:Cost of Illness; D003906:Developing Countries; D005260:Female; D005387:Finland / Q000453:epidemiology; D005544:Forecasting; D006801:Humans; D008962:Models, Theoretical; D027383:Papillomaviridae / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000150:complications / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D014765:Viral Vaccines
D053918:Papillomavirus Vaccines; D014765:Viral Vaccines